Mexafylline

This classification denotes a bronchodilator with the molecular formula C14H18N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OTS2XT15W3, chemically known as 2,6(1h,3h)-purinedione, 3-(3-cyclohexen-1-ylmethyl)-1,8-dimethyl- but generally known as mexafylline, which bears US NIH Compound Identifier 3047743. European Medicines Agency schedules Mexafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08928MIG. The term MEXAFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). MEXAFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mexafylline under HS 29395900 and SITC 54145. As of Q4 2014, MEXAFYLLINE remains the US FDA Preferred Term for this commodity. Mexafylline bears US NLM identifiers UMLS ID C2981331 and NCI Concept Code C87683. SMILES: O=C1N(CC2CCC=CC2)C2NC([NH]C2C(=O)N1C)C.